img

Global G-CSF Biosimilars Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global G-CSF Biosimilars Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
G-CSF Biosimilars report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global G-CSF Biosimilars market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Blood Disorders and Oncology Diseases are the major drivers for the industry.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product SegmentsHuman growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
Company profiles are primarily based on public domain information including company
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Pfizer
Novartis
Roche
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global G-CSF Biosimilars market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Segment by Type
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor

Segment by Application


Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the G-CSF Biosimilars market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of G-CSF Biosimilars, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the G-CSF Biosimilars industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of G-CSF Biosimilars in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, G-CSF Biosimilars introduction, etc. G-CSF Biosimilars Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of G-CSF Biosimilars market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 G-CSF Biosimilars Market Overview
1.1 G-CSF Biosimilars Product Overview
1.2 G-CSF Biosimilars Market Segment by Type
1.2.1 Human Growth Hormone
1.2.2 Erythropoietin
1.2.3 Monoclonal Antibodies
1.2.4 Insulin
1.2.5 Interferon
1.2.6 Granulocyte-Colony Stimulating Factor
1.3 Global G-CSF Biosimilars Market Size by Type
1.3.1 Global G-CSF Biosimilars Market Size Overview by Type (2018-2034)
1.3.2 Global G-CSF Biosimilars Historic Market Size Review by Type (2018-2024)
1.3.3 Global G-CSF Biosimilars Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America G-CSF Biosimilars Sales Breakdown by Type (2018-2024)
1.4.2 Europe G-CSF Biosimilars Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific G-CSF Biosimilars Sales Breakdown by Type (2018-2024)
1.4.4 Latin America G-CSF Biosimilars Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa G-CSF Biosimilars Sales Breakdown by Type (2018-2024)
2 Global G-CSF Biosimilars Market Competition by Company
2.1 Global Top Players by G-CSF Biosimilars Sales (2018-2024)
2.2 Global Top Players by G-CSF Biosimilars Revenue (2018-2024)
2.3 Global Top Players by G-CSF Biosimilars Price (2018-2024)
2.4 Global Top Manufacturers G-CSF Biosimilars Manufacturing Base Distribution, Sales Area, Product Type
2.5 G-CSF Biosimilars Market Competitive Situation and Trends
2.5.1 G-CSF Biosimilars Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by G-CSF Biosimilars Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in G-CSF Biosimilars as of 2022)
2.7 Date of Key Manufacturers Enter into G-CSF Biosimilars Market
2.8 Key Manufacturers G-CSF Biosimilars Product Offered
2.9 Mergers & Acquisitions, Expansion
3 G-CSF Biosimilars Status and Outlook by Region
3.1 Global G-CSF Biosimilars Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global G-CSF Biosimilars Historic Market Size by Region
3.2.1 Global G-CSF Biosimilars Sales in Volume by Region (2018-2024)
3.2.2 Global G-CSF Biosimilars Sales in Value by Region (2018-2024)
3.2.3 Global G-CSF Biosimilars Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global G-CSF Biosimilars Forecasted Market Size by Region
3.3.1 Global G-CSF Biosimilars Sales in Volume by Region (2024-2034)
3.3.2 Global G-CSF Biosimilars Sales in Value by Region (2024-2034)
3.3.3 Global G-CSF Biosimilars Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global G-CSF Biosimilars by Application
4.1 G-CSF Biosimilars Market Segment by Application
4.1.1 Blood Disorders
4.1.2 Oncology Diseases
4.1.3 Chronic And Autoimmune Diseases
4.1.4 Growth Hormone Deficiencies
4.2 Global G-CSF Biosimilars Market Size by Application
4.2.1 Global G-CSF Biosimilars Market Size Overview by Application (2018-2034)
4.2.2 Global G-CSF Biosimilars Historic Market Size Review by Application (2018-2024)
4.2.3 Global G-CSF Biosimilars Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America G-CSF Biosimilars Sales Breakdown by Application (2018-2024)
4.3.2 Europe G-CSF Biosimilars Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific G-CSF Biosimilars Sales Breakdown by Application (2018-2024)
4.3.4 Latin America G-CSF Biosimilars Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa G-CSF Biosimilars Sales Breakdown by Application (2018-2024)
5 North America G-CSF Biosimilars by Country
5.1 North America G-CSF Biosimilars Historic Market Size by Country
5.1.1 North America G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America G-CSF Biosimilars Sales in Volume by Country (2018-2024)
5.1.3 North America G-CSF Biosimilars Sales in Value by Country (2018-2024)
5.2 North America G-CSF Biosimilars Forecasted Market Size by Country
5.2.1 North America G-CSF Biosimilars Sales in Volume by Country (2024-2034)
5.2.2 North America G-CSF Biosimilars Sales in Value by Country (2024-2034)
6 Europe G-CSF Biosimilars by Country
6.1 Europe G-CSF Biosimilars Historic Market Size by Country
6.1.1 Europe G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe G-CSF Biosimilars Sales in Volume by Country (2018-2024)
6.1.3 Europe G-CSF Biosimilars Sales in Value by Country (2018-2024)
6.2 Europe G-CSF Biosimilars Forecasted Market Size by Country
6.2.1 Europe G-CSF Biosimilars Sales in Volume by Country (2024-2034)
6.2.2 Europe G-CSF Biosimilars Sales in Value by Country (2024-2034)
7 Asia-Pacific G-CSF Biosimilars by Region
7.1 Asia-Pacific G-CSF Biosimilars Historic Market Size by Region
7.1.1 Asia-Pacific G-CSF Biosimilars Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific G-CSF Biosimilars Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific G-CSF Biosimilars Sales in Value by Region (2018-2024)
7.2 Asia-Pacific G-CSF Biosimilars Forecasted Market Size by Region
7.2.1 Asia-Pacific G-CSF Biosimilars Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific G-CSF Biosimilars Sales in Value by Region (2024-2034)
8 Latin America G-CSF Biosimilars by Country
8.1 Latin America G-CSF Biosimilars Historic Market Size by Country
8.1.1 Latin America G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America G-CSF Biosimilars Sales in Volume by Country (2018-2024)
8.1.3 Latin America G-CSF Biosimilars Sales in Value by Country (2018-2024)
8.2 Latin America G-CSF Biosimilars Forecasted Market Size by Country
8.2.1 Latin America G-CSF Biosimilars Sales in Volume by Country (2024-2034)
8.2.2 Latin America G-CSF Biosimilars Sales in Value by Country (2024-2034)
9 Middle East and Africa G-CSF Biosimilars by Country
9.1 Middle East and Africa G-CSF Biosimilars Historic Market Size by Country
9.1.1 Middle East and Africa G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa G-CSF Biosimilars Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa G-CSF Biosimilars Sales in Value by Country (2018-2024)
9.2 Middle East and Africa G-CSF Biosimilars Forecasted Market Size by Country
9.2.1 Middle East and Africa G-CSF Biosimilars Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa G-CSF Biosimilars Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer G-CSF Biosimilars Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novartis G-CSF Biosimilars Products Offered
10.2.5 Novartis Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Roche G-CSF Biosimilars Products Offered
10.3.5 Roche Recent Development
10.4 Merck & Co.
10.4.1 Merck & Co. Company Information
10.4.2 Merck & Co. Introduction and Business Overview
10.4.3 Merck & Co. G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck & Co. G-CSF Biosimilars Products Offered
10.4.5 Merck & Co. Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Sanofi G-CSF Biosimilars Products Offered
10.5.5 Sanofi Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Johnson & Johnson G-CSF Biosimilars Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Gilead Science
10.7.1 Gilead Science Company Information
10.7.2 Gilead Science Introduction and Business Overview
10.7.3 Gilead Science G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Gilead Science G-CSF Biosimilars Products Offered
10.7.5 Gilead Science Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Information
10.8.2 GlaxoSmithKline Introduction and Business Overview
10.8.3 GlaxoSmithKline G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.8.4 GlaxoSmithKline G-CSF Biosimilars Products Offered
10.8.5 GlaxoSmithKline Recent Development
10.9 AbbVie
10.9.1 AbbVie Company Information
10.9.2 AbbVie Introduction and Business Overview
10.9.3 AbbVie G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.9.4 AbbVie G-CSF Biosimilars Products Offered
10.9.5 AbbVie Recent Development
10.10 Amgen
10.10.1 Amgen Company Information
10.10.2 Amgen Introduction and Business Overview
10.10.3 Amgen G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Amgen G-CSF Biosimilars Products Offered
10.10.5 Amgen Recent Development
10.11 AstraZeneca
10.11.1 AstraZeneca Company Information
10.11.2 AstraZeneca Introduction and Business Overview
10.11.3 AstraZeneca G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.11.4 AstraZeneca G-CSF Biosimilars Products Offered
10.11.5 AstraZeneca Recent Development
10.12 Bayer
10.12.1 Bayer Company Information
10.12.2 Bayer Introduction and Business Overview
10.12.3 Bayer G-CSF Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Bayer G-CSF Biosimilars Products Offered
10.12.5 Bayer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 G-CSF Biosimilars Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 G-CSF Biosimilars Industrial Chain Analysis
11.4 G-CSF Biosimilars Market Dynamics
11.4.1 G-CSF Biosimilars Industry Trends
11.4.2 G-CSF Biosimilars Market Drivers
11.4.3 G-CSF Biosimilars Market Challenges
11.4.4 G-CSF Biosimilars Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 G-CSF Biosimilars Distributors
12.3 G-CSF Biosimilars Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Human Growth Hormone
Table 2. Major Company of Erythropoietin
Table 3. Major Company of Monoclonal Antibodies
Table 4. Major Company of Insulin
Table 5. Major Company of Interferon
Table 6. Major Company of Granulocyte-Colony Stimulating Factor
Table 7. Global G-CSF Biosimilars Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global G-CSF Biosimilars Sales by Type (2018-2024) & (K Units)
Table 9. Global G-CSF Biosimilars Sales Market Share in Volume by Type (2018-2024)
Table 10. Global G-CSF Biosimilars Sales by Type (2018-2024) & (US& Million)
Table 11. Global G-CSF Biosimilars Market Share in Value by Type (2018-2024)
Table 12. Global G-CSF Biosimilars Price by Type (2018-2024) & (USD/Unit)
Table 13. Global G-CSF Biosimilars Sales by Type (2024-2034) & (K Units)
Table 14. Global G-CSF Biosimilars Sales Market Share in Volume by Type (2024-2034)
Table 15. Global G-CSF Biosimilars Sales by Type (2024-2034) & (US$ Million)
Table 16. Global G-CSF Biosimilars Sales Market Share in Value by Type (2024-2034)
Table 17. Global G-CSF Biosimilars Price by Type (2024-2034) & (USD/Unit)
Table 18. North America G-CSF Biosimilars Sales by Type (2018-2024) & (K Units)
Table 19. North America G-CSF Biosimilars Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe G-CSF Biosimilars Sales (K Units) by Type (2018-2024)
Table 21. Europe G-CSF Biosimilars Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific G-CSF Biosimilars Sales (K Units) by Type (2018-2024)
Table 23. Asia-Pacific G-CSF Biosimilars Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America G-CSF Biosimilars Sales (K Units) by Type (2018-2024)
Table 25. Latin America G-CSF Biosimilars Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa G-CSF Biosimilars Sales (K Units) by Type (2018-2024)
Table 27. Middle East and Africa G-CSF Biosimilars Sales by Type (2018-2024) & (US$ Million)
Table 28. Global G-CSF Biosimilars Sales by Company (2018-2024) & (K Units)
Table 29. Global G-CSF Biosimilars Sales Share by Company (2018-2024)
Table 30. Global G-CSF Biosimilars Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global G-CSF Biosimilars Revenue Share by Company (2018-2024)
Table 32. Global Market G-CSF Biosimilars Price by Company (2018-2024) & (USD/Unit)
Table 33. Global G-CSF Biosimilars Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global G-CSF Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in G-CSF Biosimilars as of 2022)
Table 36. Date of Key Manufacturers Enter into G-CSF Biosimilars Market
Table 37. Key Manufacturers G-CSF Biosimilars Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global G-CSF Biosimilars Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global G-CSF Biosimilars Sales by Region (2018-2024) & (K Units)
Table 41. Global G-CSF Biosimilars Sales Market Share in Volume by Region (2018-2024)
Table 42. Global G-CSF Biosimilars Sales by Region (2018-2024) & (US$ Million)
Table 43. Global G-CSF Biosimilars Sales Market Share in Value by Region (2018-2024)
Table 44. Global G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 45. Global G-CSF Biosimilars Sales by Region (2024-2034) & (K Units)
Table 46. Global G-CSF Biosimilars Sales Market Share in Volume by Region (2024-2034)
Table 47. Global G-CSF Biosimilars Sales by Region (2024-2034) & (US$ Million)
Table 48. Global G-CSF Biosimilars Sales Market Share in Value by Region (2024-2034)
Table 49. Global G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 50. Global G-CSF Biosimilars Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global G-CSF Biosimilars Sales by Application (2018-2024) & (K Units)
Table 52. Global G-CSF Biosimilars Sales Market Share in Volume by Application (2018-2024)
Table 53. Global G-CSF Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 54. Global G-CSF Biosimilars Sales Market Share in Value by Application (2018-2024)
Table 55. Global G-CSF Biosimilars Price by Application (2018-2024) & (USD/Unit)
Table 56. Global G-CSF Biosimilars Sales by Application (2024-2034) & (K Units)
Table 57. Global G-CSF Biosimilars Sales Market Share in Volume by Application (2024-2034)
Table 58. Global G-CSF Biosimilars Sales by Application (2024-2034) & (US$ Million)
Table 59. Global G-CSF Biosimilars Sales Market Share in Value by Application (2024-2034)
Table 60. Global G-CSF Biosimilars Price by Application (2024-2034) & (USD/Unit)
Table 61. North America G-CSF Biosimilars Sales by Application (2018-2024) (K Units)
Table 62. North America G-CSF Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe G-CSF Biosimilars Sales by Application (2018-2024) (K Units)
Table 64. Europe G-CSF Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific G-CSF Biosimilars Sales by Application (2018-2024) (K Units)
Table 66. Asia-Pacific G-CSF Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America G-CSF Biosimilars Sales by Application (2018-2024) (K Units)
Table 68. Latin America G-CSF Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa G-CSF Biosimilars Sales by Application (2018-2024) (K Units)
Table 70. Middle East and Africa G-CSF Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 71. North America G-CSF Biosimilars Sales by Country (2018-2024) & (K Units)
Table 72. North America G-CSF Biosimilars Sales Market Share in Volume by Country (2018-2024)
Table 73. North America G-CSF Biosimilars Sales by Country (2018-2024) & (US$ Million)
Table 74. North America G-CSF Biosimilars Sales Market Share in Value by Country (2018-2024)
Table 75. North America G-CSF Biosimilars Sales by Country (2024-2034) & (K Units)
Table 76. North America G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 77. North America G-CSF Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 78. North America G-CSF Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 79. Europe G-CSF Biosimilars Sales by Country (2018-2024) & (K Units)
Table 80. Europe G-CSF Biosimilars Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe G-CSF Biosimilars Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe G-CSF Biosimilars Sales Market Share in Value by Country (2018-2024)
Table 83. Europe G-CSF Biosimilars Sales by Country (2024-2034) & (K Units)
Table 84. Europe G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe G-CSF Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe G-CSF Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific G-CSF Biosimilars Sales by Region (2018-2024) & (K Units)
Table 88. Asia-Pacific G-CSF Biosimilars Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific G-CSF Biosimilars Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific G-CSF Biosimilars Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific G-CSF Biosimilars Sales by Region (2024-2034) & (K Units)
Table 92. Asia-Pacific G-CSF Biosimilars Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific G-CSF Biosimilars Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific G-CSF Biosimilars Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America G-CSF Biosimilars Sales by Country (2018-2024) & (K Units)
Table 96. Latin America G-CSF Biosimilars Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America G-CSF Biosimilars Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America G-CSF Biosimilars Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America G-CSF Biosimilars Sales by Country (2024-2034) & (K Units)
Table 100. Latin America G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America G-CSF Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America G-CSF Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa G-CSF Biosimilars Sales by Country (2018-2024) & (K Units)
Table 104. Middle East and Africa G-CSF Biosimilars Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa G-CSF Biosimilars Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa G-CSF Biosimilars Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa G-CSF Biosimilars Sales by Country (2024-2034) & (K Units)
Table 108. Middle East and Africa G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa G-CSF Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa G-CSF Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 111. Pfizer Company Information
Table 112. Pfizer Introduction and Business Overview
Table 113. Pfizer G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 114. Pfizer G-CSF Biosimilars Product
Table 115. Pfizer Recent Development
Table 116. Novartis Company Information
Table 117. Novartis Introduction and Business Overview
Table 118. Novartis G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 119. Novartis G-CSF Biosimilars Product
Table 120. Novartis Recent Development
Table 121. Roche Company Information
Table 122. Roche Introduction and Business Overview
Table 123. Roche G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 124. Roche G-CSF Biosimilars Product
Table 125. Roche Recent Development
Table 126. Merck & Co. Company Information
Table 127. Merck & Co. Introduction and Business Overview
Table 128. Merck & Co. G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 129. Merck & Co. G-CSF Biosimilars Product
Table 130. Merck & Co. Recent Development
Table 131. Sanofi Company Information
Table 132. Sanofi Introduction and Business Overview
Table 133. Sanofi G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 134. Sanofi G-CSF Biosimilars Product
Table 135. Sanofi Recent Development
Table 136. Johnson & Johnson Company Information
Table 137. Johnson & Johnson Introduction and Business Overview
Table 138. Johnson & Johnson G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 139. Johnson & Johnson G-CSF Biosimilars Product
Table 140. Johnson & Johnson Recent Development
Table 141. Gilead Science Company Information
Table 142. Gilead Science Introduction and Business Overview
Table 143. Gilead Science G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 144. Gilead Science G-CSF Biosimilars Product
Table 145. Gilead Science Recent Development
Table 146. GlaxoSmithKline Company Information
Table 147. GlaxoSmithKline Introduction and Business Overview
Table 148. GlaxoSmithKline G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 149. GlaxoSmithKline G-CSF Biosimilars Product
Table 150. GlaxoSmithKline Recent Development
Table 151. AbbVie Company Information
Table 152. AbbVie Introduction and Business Overview
Table 153. AbbVie G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 154. AbbVie G-CSF Biosimilars Product
Table 155. AbbVie Recent Development
Table 156. Amgen Company Information
Table 157. Amgen Introduction and Business Overview
Table 158. Amgen G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 159. Amgen G-CSF Biosimilars Product
Table 160. Amgen Recent Development
Table 161. AstraZeneca Company Information
Table 162. AstraZeneca Introduction and Business Overview
Table 163. AstraZeneca G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 164. AstraZeneca G-CSF Biosimilars Product
Table 165. AstraZeneca Recent Development
Table 166. Bayer Company Information
Table 167. Bayer Introduction and Business Overview
Table 168. Bayer G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 169. Bayer G-CSF Biosimilars Product
Table 170. Bayer Recent Development
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. G-CSF Biosimilars Market Trends
Table 174. G-CSF Biosimilars Market Drivers
Table 175. G-CSF Biosimilars Market Challenges
Table 176. G-CSF Biosimilars Market Restraints
Table 177. G-CSF Biosimilars Distributors List
Table 178. G-CSF Biosimilars Downstream Customers
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. G-CSF Biosimilars Product Picture
Figure 2. Global G-CSF Biosimilars Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global G-CSF Biosimilars Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global G-CSF Biosimilars Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Human Growth Hormone
Figure 6. Global Human Growth Hormone Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Erythropoietin
Figure 8. Global Erythropoietin Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Global Monoclonal Antibodies Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Insulin
Figure 12. Global Insulin Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Interferon
Figure 14. Global Interferon Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Product Picture of Granulocyte-Colony Stimulating Factor
Figure 16. Global Granulocyte-Colony Stimulating Factor Sales YoY Growth (2018-2034) & (K Units)
Figure 17. Global G-CSF Biosimilars Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global G-CSF Biosimilars Sales Market Share by Type in 2022 & 2034
Figure 19. North America G-CSF Biosimilars Sales Market Share in Volume by Type in 2022
Figure 20. North America G-CSF Biosimilars Sales Market Share in Value by Type in 2022
Figure 21. Europe G-CSF Biosimilars Sales Market Share in Volume by Type in 2022
Figure 22. Europe G-CSF Biosimilars Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific G-CSF Biosimilars Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific G-CSF Biosimilars Sales Market Share in Value by Type in 2022
Figure 25. Latin America G-CSF Biosimilars Sales Market Share in Volume by Type in 2022
Figure 26. Latin America G-CSF Biosimilars Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa G-CSF Biosimilars Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa G-CSF Biosimilars Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by G-CSF Biosimilars Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by G-CSF Biosimilars Revenue in 2022
Figure 31. G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Blood Disorders
Figure 33. Global Blood Disorders Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Oncology Diseases
Figure 35. Global Oncology Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Chronic And Autoimmune Diseases
Figure 37. Global Chronic And Autoimmune Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Product Picture of Growth Hormone Deficiencies
Figure 39. Global Growth Hormone Deficiencies Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Global G-CSF Biosimilars Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global G-CSF Biosimilars Sales Market Share by Application in 2022 & 2034
Figure 42. North America G-CSF Biosimilars Sales Market Share in Volume by Application in 2022
Figure 43. North America G-CSF Biosimilars Sales Market Share in Value by Application in 2022
Figure 44. Europe G-CSF Biosimilars Sales Market Share in Volume by Application in 2022
Figure 45. Europe G-CSF Biosimilars Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific G-CSF Biosimilars Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific G-CSF Biosimilars Sales Market Share in Value by Application in 2022
Figure 48. Latin America G-CSF Biosimilars Sales Market Share in Volume by Application in 2022
Figure 49. Latin America G-CSF Biosimilars Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa G-CSF Biosimilars Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. G-CSF Biosimilars Manufacturing Cost Structure
Figure 53. G-CSF Biosimilars Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries